John L. Marshall of Lombardi Comprehensive Cancer Institute discusses how the results of the RESORCE Trial will impact treatment for HCC patients at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
How Will the Results of the RESORCE Trial Impact HCC Treatment
